V3 loop of human immunodeficiency virus type 1 suppresses interleukin 2- induced T cell growth

AIDS Research and Human Retroviruses

Volumn 13, Issue 2, 1997, Pages 151-160

  Sakaida, Hitoshi ^a   Murakami, Toshio ^a,b   Kawamata, Shin ^a   Hattori, Toshio ^a   Uchiyama, Takashi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Chemo Sero Therapeutic Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ARTICLE; CELL CYCLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031012812     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.151     Document Type: Article

References (56)

1. Barré-Sinoussi F, Chermann JC, Ray P, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vézinet-Brun F, Rouzioux C, Rozenbaum W, and Montagnier L: Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868-871.
2. Fauci AS: The immunodeficiency virus: Infectivity and mechanisms of pathogenesis. Science 1988;239:617-622.
3. Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, Palker TJ, Redfield R, Oleske J, Safai B, White G, Foster P, and Markham PD: Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984;224:500-503.
4. Levy JA: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993;57:183-289.
5. Connor RIJ, Mohri H, Cao Y, and Ho DD: Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in HIV-1-infected individuals. J Virol 1993;67:1772-1777.
6. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, and Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 1993;362:359-362.
7. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, and Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 1993;362:355-358.
8. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, and Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 1995;373:123-126.
9. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, and Shaw GM: Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 1995;373:117-122.
10. Groux H, Torpier G, Monté D, Mouton Y, Capron A, and Ameisen JC: Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992;175:331-340.
11. Se-Kyung Oh, Cruikshank WW, Raina J, Blanchard GC, Adler WH, Walker J, and Kornfeld H: Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J AIDS 1992;5:251-256.
12. Oyaizu N, Chirmule N, Ohnishi Y, Kalyanaraman VS, and Pahwa S: Human immunodeficiency virus type 1 envelope glycoproteins gp120 and gp160 induce interleukin-6 production in CD4+ T-cell clones. J Virol 1991;65:6277-6282.
13. Chirmule N, Kalyanaraman VS, Oyaizu N, Slade H, and Pahwa S: Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein gp120 of human immunodeficiency virus. Blood 1990;75:152-159.
14. Rusche JR, Javaherian K, McDanal C, Petro J, Lynn DL, Grimaila R, Langlois A, Gallo RC, Arthur LO, Fischinger PJ, Bolognesi DP, Putney SD, and Matthews TJ: Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc Natl Acad Sci USA 1988;85:3198-3202.
15. Takahashi H, Cohen J, Hosmalin A, Cease KB, Houghten R, Comette JL, DeLisi C, Moss B, Germain RN, and Berzofsky JA: An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc Natl Acad Sci USA 1988;85:3105-3109.
16. Hattori T, Koito S, Takatuki K, Kido H, and Katunuma N: Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection. FEBS Lett 1989;248:48-52.
17. Murakami T, Hattori T, and Takatuki K: A principal neutralizing domain of human immunodeficiency virus type 1 interacts with proteinase-like molecule(s) at the surface of Molt-4 clone 8 cells. Biochim Biophys Acta 1991;1079:279-284.
18. Oyaizu N, Chirmule N, Kalyanaraman VS, Hall WW, Good RA, and Pahwa S: Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA. Proc Natl Acad Sci USA 1990;87:2379-2383.
19. Ratner L, Haseltine W, Patarca R, Livak KJ, Starcich B, Josephs SF, Doran ER, Rafalski JA, Whitehorn EA, Baumeister K, Ivanoff L, Petteway SR Jr, Pearson ML, Lautenberger JA, Papas TS, Ghrayeb J, Chang NT, Gallo RC, and Wong-Staal F: Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature (London) 1985;313:277-284.
20. Levy JA, Hoffman AD, Kramer SM, Landis JA, Shimabukuro JM, and Oshiro LS: Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 1984;225:840-842.
21. Shioda T, Levy JA, and Chen-Mayer C: Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1992;89:9434-9438.
22. Koito A, Harrowe G, Levy JA, and Chen-Mayer C: Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization. J Virol 1994;68:2253-2259.
23. Matsushita S, Robert-Guroff M, Rusche J, Koito A, Hattori T, Hoshino H, Javaherian K, Takatuki K, and Putney S: Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J Virol 1988;62:2107-2114.
24. Hori T, Uchiyama T, Tsudo M, Umadome H, Ohno H, Fukuhara S, Kita K, and Uchino H: Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus. Blood 1987;70:1069-1072.
25. Maeda M, Shimizu A, Ikuta K, Okamoto H, Kashihara M, Uchiyama T, Honjo T, and Yodoi J: Origin of human T-lymphotropic virus I-positive T cell lines in adult T cell leukemia. J Exp Med 1985;162:2169-2174.
26. Shimizu S, Takiguchi T, Sugai S, Matsuoka M, and Konda S: An established CD4+ T lymphoma cell line derived from a patient with so-called Lennert's lymphoma: Possible roles of cytokines in histopathogenesis. Blood 1988;71:196-203.
27. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, and Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-7419.
28. Chesbro B and Wehrly K: Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J Virol 1988;62:3779-3788.
29. Pincus SH, Messer KG, Schwartz DH, Lewis GK, Graham BS, Blattner WA, and Fischer G: Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccines. J Clin Invest 1993;91:1987-1996.
30. Shapiro HM: Flow cytometric estimation of DNA and RNA content in intact cells stained with Hoechst33342 and pyronin Y. Cytometry 1981;2:143-150.
31. Arima N, Kamio M, Okuma M, Ju G, and Uchiyama T: The IL-2 receptor α-chain alters the binding of IL-2 to the β-chain. J Immunol 1991;147:3396-3401.
32. Dibirdik I, Langlie MC, Ledbetter JA, Tuel-Ahlgren L, Obuz V, Waddick KG, Gajl-Peczalska K, Scieven GL, and Uckun FM: Engagement of interleukin-7 receptor stimulates tyrosine phosphorylation, phosphoinositide turnover, and clonal proliferation of human T-lineage acute lymphoblastic leukemia cells. Blood 1991;78:564-570.
33. Chomczynski P and Sacchi N: Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
34. Miller AD, Curran T, and Verma IM: c-Fos protein can induce cellular transformation: A novel mechanism of activation of a cellular oncogene. Cell 1984;36:51-60.
35. Straaten FV, Müller R, Curran T, Beveren CV, and Verma IM: Complete nucleotide sequence of a human c-onc gene: Deduced amino acid sequence of the human c-Fos protein. Proc Natl Acad Sci USA 1983;80:3183-3187.
36. Nomura N, Ide M, Sasamato S, Matsui M, Date T, and Ishizaka R: Isolation of human cDNA clones of jun-related genes, jun-B and jun-D. Nucleic Acids Res 1990;18:3047-3048.
37. Battey J, Moulding C, Taub R, Murphy W, Steward T, Potter H, Lenoir G, and Leder P: The human c-myc oncogene: Structural consequences of translocation into the IgH locus in Burkitt lymphoma. Cell 1983;34:779-787.
38. Murakami T, Matushita S, Maeda Y, Takatuki K, Uchiyama T, and Hattori T: Applications of biotinylated V3 loop peptides of human immunodeficiency virus type 1 to flow cytometric analysis and affinity chromatographic techniques. Biochim Biophys Acta 1993;1181:155-162.
39. Xu Y, Murakami T, Kawase S, Uchiyama T, and Hattori T: Characterization of V3 loop-binding protein(s) of Molt-4 and U937 cells. AIDS Res Hum Retroviruses 1995;11:563-570.
40. Kolesnitchenko V, Wahl LM, Tian H, Sunila I, Tani Y, Hartmann DP, Cossman J, Raffeld M, Orenstein J, and Samelson LE: Human immunodeficiency virus 1 envelope-initiated G2-phase programmed cell death. Proc Natl Acad Sci USA 1995;92: 11889-11893.
41. Cantrell DA and Smith KA: The interleukin-2 T-cell system: A new cell growth model. Science 1984;224:1312-1316.
42. Cantrell DA and Smith KA: Transient expression of interleukin 2 receptors consequences for T cell growth. J Exp Med 1983; 158:1895-1911.
43. Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly RP, and Finkel TH: Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 1992;176:1099-1106.
44. Oyaizu N, McCloskey TW, Than S, Hu R, Kalyanaraman VS, and Pahwa S: Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-γ and tumor necrosis factor-α secretion. Blood 1994;84:2622-2631.
45. Palker TJ, Matthews TJ, Langlois A, Tanner ME, Martin ME, Scearce RM, Kim JE, Berzofsky JA, Bolognesi DP, and Haynes BF: Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes. J Immunol 1989;142:3612-3619.
46. Estaquier J, Gras-Masse H, Boutillon C, Ameisen JC, Capron A, Tartar A, and Auriault C: The mixtope: A combinatorial peptide library as a T cell and B cell immunogen. Eur J Immunol 1994;24:2789-2795.
47. Sastry KJ, Nehete PN, Venkatnarayanan S, Morkowski J, Platsoucas CD, and Arlinghaus RB: Rapid in vivo induction of HIV-specific CD8+ cytotoxic T lymphocytes by a 15-amino acid unmodified free peptide from the immunodominant V3-loop of gp120. Virology 1992;188:502-509.
48. Sheryl VM, Tse H, Rosenspire AJ, and King SR: CD4-independent inhibition of lymphocyte proliferation mediated by HIV-1 envelope glycoproteins. Virology 1992;191:973-977.
49. Sattentau QJ and Moore JP: Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J Exp Med 1991;174:407-415.
50. Wyatt R, Moore J, Accola M, Desjardin E, Robinson J, and Sodroski J: Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J Virol 1995;69:5723-5733.
51. Earl PL, Domes RW, and Moss B: Oligomeric structure of the human immunodeficiency virus type 1 envelope protein. Proc Natl Acad Sci USA 1990;87:648-652.
52. Einfeld D and Hunter E: Oligomeric structure of a prototype retrovirus glycoprotein. Proc Natl Acad Sci USA 1988;85:8688-8692.
53. Gelderblom HR, Ozel M, and Pauli G: Morphogenesis and morphology of HIV: Structure-function relationships. Arch Virol 1989;106:1-13.
54. Weiss CD, Levy JA, and White JM: Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles. J Virol 1990;54:5674-5677.
55. Schawaller M, Smith GE, Skehel JJ, and Wiley DC: Studies with cross-linking reagents on the oligomeric structure of the Env glycoprotein of HIV. Virology 1989;172:367-369.
56. Gius D, Cao X, Rauscher FJ III, Cohen DR, Curran T, and Sukhatme VP: Transcriptional activation and repression by Fos are independent functions: The C terminus represses immediate-early gene expression via CArG elements. Mol Cell Biol 1990; 10:4243-4255.